publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
viral
proteas
inhibitor
http
dx
alphavirus
belong
togavirida
group
iv
famili
virus
categor
c
prioriti
pathogen
accord
us
nation
institut
allergi
infecti
diseas
unit
state
america
virus
known
caus
major
fatal
due
high
mortal
morbid
rate
underdevelop
region
africa
asia
part
latin
america
strauss
strauss
alphavirus
abl
infect
variou
vertebr
human
hors
rodent
fish
bird
well
invertebr
includ
numer
categori
virus
chikungunya
viru
chikv
barmah
forest
viru
onyongnyong
viru
mayaro
viru
rose
river
viru
semiliki
forest
viru
sfv
sindbi
viru
sinv
una
viru
tonat
viru
eastern
equin
enceph
western
equin
enceph
venezuelan
equin
virus
atkin
infect
caus
virus
potenti
risk
mani
far
treatment
treatment
manag
vaccin
procedur
combat
diseas
caus
virus
reward
rayner
et
al
alphavirus
gener
rna
virus
positivesens
singlestrand
rna
genom
koonin
et
al
rna
virus
encod
nonstructur
ns
protein
nsp
use
replic
achiev
matur
state
protein
moieti
target
develop
test
potenti
antivir
drug
goal
comput
studi
provid
altern
tool
highli
reliabl
may
complementari
current
experiment
techniqu
two
import
theoret
approach
molecular
dynam
simul
chowdhuri
dock
agarw
et
al
bissoyi
et
al
found
quit
reliabl
respect
comput
procedur
wide
util
investig
drugreceptor
interact
variou
type
biochem
problem
garg
et
al
gupta
et
al
recent
sever
proteas
inhibitor
develop
use
computeraid
drug
design
methodolog
gupta
gupta
et
al
wlodaw
vondrasek
synthet
approach
highthroughput
screen
method
mayr
bojan
drug
repositionbas
approach
sundberg
could
possibl
target
nsp
respons
viru
replic
addit
proteas
inhibitor
target
viral
nsp
also
isol
variou
sourc
plant
extract
bhakat
et
al
proteas
inhibitor
shown
differ
degre
inhibit
viral
nsp
necessit
develop
select
potent
therapeut
agent
devast
alphavirus
de
francesco
carfi
chapter
attempt
made
discuss
develop
design
antivir
drug
variou
alphavirus
addit
develop
proteas
inhibitor
target
nsp
alphavirus
also
present
alphavirus
establish
model
system
examin
bud
assembl
envelop
virus
rna
genom
virus
encod
multipl
copi
capsid
protein
cp
assembl
along
replic
rna
form
nucleocapsid
core
nc
icosahedr
bud
assembl
pattern
simpl
envelop
virus
describ
detail
alphavirus
invad
host
cell
clathrinco
endocyt
pathway
acid
ph
endosom
membran
enabl
fusion
result
releas
nc
cytoplasm
upon
shift
cp
ribosom
nc
becom
uncoat
discharg
rna
genom
cytoplasm
genom
rna
translat
nsp
inform
negativesens
replica
genom
rna
transcrib
nsp
rna
work
archetyp
product
genom
subgenom
rna
subgenom
rna
greater
capabl
synthes
protein
comparison
genom
rna
also
encod
basic
protein
viru
structur
polyprotein
cp
nterminu
follow
alphaviru
virion
form
assembl
copi
cp
fig
transmembran
glycoprotein
mediat
coalesc
viral
endosom
membran
hand
transmembran
segment
respons
bind
cell
receptor
endoplasm
reticulum
er
golgi
apparatu
process
precursor
heterodim
transport
form
spike
cell
surfac
spike
constitut
three
heterodim
promot
correct
fold
work
chaperon
prevent
prematur
fusion
golgi
acid
ph
environ
viru
entri
fusion
glycoprotein
spike
complex
produc
cleavag
golgi
help
proteas
similar
furin
function
clear
promot
pathogen
effect
particl
infect
cell
icosahedr
nc
form
cytoplasm
encas
copi
genom
rna
copi
cp
matur
viru
bud
host
cell
membran
action
nc
trimer
spike
present
plasma
membran
conform
alphavirus
fig
clearli
defin
two
popular
techniqu
imag
reconstruct
techniqu
cryoelectron
microscopi
cryoem
outer
protein
layer
virus
consist
glycoprotein
fig
membran
extens
glycoprotein
pass
lipid
bilay
host
enclos
nc
viru
interact
cp
glycoprotein
layer
proport
organ
icosahedr
configur
pseudoatom
model
viru
gener
amino
acid
sequenc
cp
crystal
arrang
part
protein
extend
extracellular
space
fit
cryoem
densiti
sinv
observ
exterior
surfac
viral
membran
take
icosahedr
shell
shape
bind
cryoem
densiti
practic
posit
later
radial
lipid
bilay
simultan
top
popul
cloak
fusion
peptid
prevent
earli
synthesi
cell
membran
envelop
glycoprotein
requir
cell
entri
exterior
unveil
approach
cellular
receptor
protect
fusion
complet
separ
endosom
low
ph
fusion
peptid
expos
bind
amino
acid
cp
cryoem
densiti
sinv
exhibit
everi
singl
subunit
promin
pentam
well
hexam
known
capsomer
detect
nc
layer
made
cp
proteas
domain
compris
amino
acid
inde
minor
contact
observ
cp
amino
acid
capsomer
accordingli
nc
stabil
absenc
glycoprotein
rnarna
cprna
interact
connect
cprna
rnarna
appear
rnaprotein
layer
capsomer
nsp
essenti
replic
process
alphaviru
addit
nsp
also
play
vital
role
infect
interact
viru
host
cell
four
nsp
aa
whose
structur
shown
fig
bind
membran
protein
activ
guanylyl
transferas
methyl
transferas
involv
cover
rna
ahola
ahola
koonin
et
al
laakkonen
et
al
respons
alphaviru
cap
methyl
group
transfer
sadenosyl
methionin
adomet
gtp
subsequ
transfer
viru
rna
coval
complex
form
respons
cap
alphaviru
somewhat
differ
cap
cellular
mrna
guanylyl
transferas
first
transmit
gmp
rna
follow
methyl
gmprna
ahola
enzymat
action
necessari
viru
replic
viru
becom
noninfecti
singlepoint
mutat
transform
abolish
enzymat
activ
wang
et
al
strongli
bound
plasma
membran
infect
cell
express
alon
function
singl
membran
anchor
viru
replic
complex
et
al
salonen
et
al
et
al
amphipath
alphahelix
form
amino
acid
mediat
bind
plasma
membran
ahola
et
al
bind
activ
membran
affect
singlepoint
mutat
lethal
viru
et
al
sfv
cy
residu
sinv
tighten
membran
bind
posttransl
palmitoyl
laakkonen
et
al
wang
et
al
et
al
palmitoyl
requir
format
replic
complex
sustain
viru
enzymat
activ
ahola
et
al
howev
remov
exchang
cystein
residu
sfv
significantli
obstruct
viru
duplic
caus
growth
explet
alter
et
al
observ
viru
express
palmitoylationdefici
capabl
caus
diseas
mice
virus
induc
low
level
virus
blood
stream
infect
observ
brain
tissu
ahola
respons
initi
structur
cell
surfac
similar
filopodia
repres
alphavirussept
cell
hardi
strauss
laakkonen
et
al
rikkomen
et
al
function
activ
signific
filopodialik
structur
palmitoyl
remain
unidentifi
four
nsp
aa
sfv
known
differ
type
enzymat
action
signific
role
viru
infect
ntermin
domain
rna
helicas
compris
activ
nucleosid
triphosphatas
represent
surfac
charg
distribut
respect
protein
blue
color
repres
posit
charg
region
orang
neg
charg
region
b
cartoon
represent
protein
protein
structur
chikv
design
use
tasser
server
zhang
structur
drawn
use
chimera
visual
tool
pettersen
et
al
rna
triphosphatas
shown
fig
et
al
lastarza
et
al
merit
et
al
et
al
rikkomen
activ
rna
helicas
rna
triphosphatas
import
unwind
rna
duplex
replic
remov
respect
viral
rna
cap
reaction
remov
guanylyl
transferas
activ
crucial
step
facilit
attach
papainlik
proteas
activ
present
ctermin
domain
respons
process
ns
polyprotein
cruz
et
al
fazakerley
et
al
moreov
proteas
particip
format
replic
complex
subsequ
regul
replic
process
proteolyt
activ
also
shown
hamper
due
mutat
abolish
effici
activ
lead
fatal
viru
cruz
et
al
cterminu
contain
latent
methyl
transfer
activ
play
import
role
regul
minusstrand
synthesi
develop
cytopath
effect
cruz
et
al
document
approxim
present
nuclear
fraction
infect
cell
evidenc
cell
fraction
studi
et
al
nuclear
transport
start
earliest
infect
nuclear
local
mediat
pentapeptid
prrrv
aa
rikkomen
nuclear
transloc
shown
affect
mutat
result
attenu
phenotyp
reduc
cytotox
transcript
translat
shutdown
host
cell
yet
render
viru
pathogen
adult
mice
fazakerley
et
al
rikkomen
addit
apart
helicaseand
methyltransferaselik
domain
sequencesdomain
within
essenti
virusinduc
shutdown
cellular
transcript
akhrymuk
et
al
firth
et
al
gorchakov
et
al
strauss
strauss
varadhachari
et
al
suppress
antivir
respons
akhrymuk
et
al
gorchakov
et
al
primari
structur
aa
sfv
compos
three
discret
domain
contain
small
macro
domain
amino
acid
nterminu
conserv
among
alphavirus
rubella
viru
hepat
e
viru
coronavirus
fig
conserv
macro
domain
also
share
sequenc
similar
macro
domain
protein
eukaryot
organ
archaea
eubacteria
koonin
et
al
pehrson
fuji
middl
domain
alphaviru
conserv
region
third
ctermin
domain
start
sfv
hypervari
length
sequenc
strauss
strauss
howev
function
clearli
understood
studi
replic
complex
suggest
found
cytoplasm
form
aggreg
irregular
boundari
variabl
size
addit
small
fraction
local
nuclear
envelop
gorchakov
et
al
wang
et
al
suggest
might
particip
rna
replic
also
demonstr
enzymat
activ
resid
within
macro
domain
protein
identifi
activ
malet
et
al
neuvonen
ahola
alphaviru
macro
domain
found
capabl
bind
poli
adpribos
rna
adpribos
shown
fig
malet
et
al
neuvonen
ahola
interestingli
poli
adpribos
interact
sinv
replic
complex
ctermin
domain
neuron
cell
park
griffin
recent
studi
suggest
alphaviru
capabl
get
phosphoryl
serinethreonin
residu
cterminu
et
al
vihinen
saarinen
vihinen
et
al
sfv
phosphoryl
site
identifi
accumul
area
acid
residu
complet
remov
site
led
reduc
level
rna
synthesi
cultur
cell
subsequ
reduc
pathogen
mice
vihinen
et
al
phosphoryl
specif
import
minusstrand
rna
synthesi
evidenc
sinvmut
studi
vihinen
et
al
thu
sfv
sinv
studi
conclud
play
signific
role
modul
neuropathogenesi
mice
tuittila
hinkkanen
sever
studi
report
also
mediat
movement
alphaviru
replic
complex
plasma
membran
intracellular
vesicl
confirm
analysi
subcellular
local
differ
form
nsp
intermedi
hahn
et
al
park
griffin
tanno
et
al
among
nsp
alphaviru
aa
sfv
fig
repres
last
catalyt
subunit
alphaviru
act
rnadepend
rna
polymeras
rdrp
hahn
et
al
tanno
et
al
ctermin
end
alphaviru
contain
gdd
motif
share
sequenc
homolog
rdrp
virus
argo
et
al
chikv
ec
local
sequenc
posit
polyprotein
nsp
constitut
amino
acid
activ
polymeras
potenti
catalyt
site
bear
triad
two
alloster
bind
site
identifi
similar
hepat
c
viru
hcv
polymeras
chikv
includ
highli
conserv
catalyt
triad
gdd
motif
respons
polymeras
activ
volumin
catalyt
site
wherea
two
alloster
bind
site
volum
identifi
palm
thumb
site
howev
ntermin
end
conserv
alphavirus
although
major
catalyt
core
replic
complex
alphaviru
still
need
nsp
activ
rubach
et
al
mutat
studi
suggest
nterminu
interact
host
protein
nsp
particularli
activ
fata
et
al
shirako
et
al
addit
vitro
experi
demonstr
also
termin
adenylyl
transferas
activ
suggest
role
repair
mainten
poli
tail
viral
genom
shirako
strauss
tomar
et
al
essenti
step
surviv
viru
level
report
lower
level
nsp
infect
cell
attain
sever
process
first
normal
translat
differ
ns
polyprotein
form
due
fact
alpha
virus
hold
opal
termin
codon
genom
moreov
translat
found
effici
second
ntermin
amino
acid
conserv
tyrosin
direct
rapid
proteasom
degrad
destabil
role
tyrosin
confirm
replac
nonaromat
residu
lead
poor
rna
replic
shirako
strauss
target
ntermin
respons
methyl
guanyl
transferas
activ
would
inhibitori
effect
viral
replic
recent
protein
show
crucial
role
downregul
bone
marrow
stromal
thu
pave
way
develop
chemic
act
tokarev
et
al
one
import
defens
mechan
host
cell
occur
express
interferon
alpha
express
result
retain
viru
surfac
infect
cell
jone
et
al
target
gene
silenc
specif
viral
protein
studi
sever
group
research
waterhous
et
al
small
hairpin
rna
shrna
show
noncelltyp
specif
antivir
effect
broadspectrum
silenc
differ
type
strain
alphavirus
lam
et
al
cell
clone
express
shrna
chikv
gene
display
inhibit
activ
chikv
product
degrad
viral
singlestrand
rna
advanc
determin
crystal
structur
virus
nsp
macro
domain
determin
provid
platform
develop
new
inhibitor
target
alphavirus
recent
consid
import
target
develop
antivir
drug
role
viral
replic
pathogenesi
cand
ntermin
activ
site
past
chemic
constitu
act
drug
extract
natur
product
base
cellular
highthroughput
screen
natur
compound
led
discoveri
natur
inhibitor
lucashourani
et
al
compound
four
analog
fig
display
potent
select
antivir
activ
toward
chikv
result
might
initi
futur
effort
discoveri
novel
natur
compound
select
inhibitor
recent
six
peptid
sequenc
obtain
global
sequenc
construct
variou
strain
alphaviru
base
phylogenet
global
conserv
singh
et
al
silico
analysi
show
peptid
sequenc
posit
bind
tabl
molecular
dynam
simul
molecular
dock
method
high
throughput
screen
singh
et
al
studi
chikungunya
viru
proteas
protein
investig
residu
involv
cleavag
mechan
compound
finess
score
consid
dock
studi
studi
identifi
four
differ
compound
potenti
inhibitor
toward
c
termin
domain
protein
per
dock
analysi
residu
found
crucial
interact
nsp
complex
cleav
consid
individu
function
unit
propag
replic
chikv
depend
protein
inhibit
protein
target
main
residu
use
molecular
model
viral
screen
bassetto
et
al
explor
target
discoveri
develop
differ
select
inhibitor
chikv
replic
discov
seri
inhibitor
chikv
silico
analysi
show
compound
bind
central
portion
proteas
hyrazon
cyclopropyl
group
shown
play
vital
role
antivir
activ
compound
furthermor
found
antivir
activ
increas
cyclopropyl
group
replac
transethenyl
moieti
shown
fig
neurotrop
alphavirus
repres
emerg
pathogen
potenti
widespread
dissemin
abil
caus
substanti
mortal
morbid
thieno
pyrrol
fig
base
structureact
relationship
analysi
potenti
novel
antivir
drug
compound
identifi
compound
shown
fig
found
possess
activ
neutrophil
alphaviru
venezuelan
equin
enceph
viru
thienopyrrol
deriv
design
homolog
model
protein
sequenc
shown
effect
inhibitor
nsp
protein
respons
chikv
replic
caus
gener
host
shutoff
prevent
ifninduc
gene
express
chikv
suppress
antivir
ifn
respons
bora
use
homolog
model
predict
threedimension
structur
proteas
model
ligand
propoxymethyl
found
bind
effici
ligand
methanol
ligand
shown
fig
one
hydrogen
bond
found
form
ligand
carbonyl
nitrogen
atom
pyrimidin
ring
ligand
form
hydrogen
bond
carbonyl
oxygen
bond
distanc
ligand
higher
gold
score
ligand
former
ligand
therefor
suppos
promis
inhibitor
proteas
chikv
viru
emerg
one
promis
antivir
drug
candid
potenti
symptomat
diseasemodifi
effect
molecular
model
autodock
molecular
dynam
simul
agarw
et
al
elucid
differ
structur
aspect
protein
differ
ligand
shown
follow
fig
ligand
shown
fig
interact
protein
three
hydrogen
bond
bond
length
amino
acid
residu
ligand
number
show
better
affin
toward
chikv
proteas
bind
energi
kcalmol
interact
amino
acid
residu
proteas
via
two
hydrogen
bond
bond
length
bind
energi
ligand
ligand
found
rang
kcalmol
ligand
common
bind
site
ligand
interact
catalyt
amino
acid
residu
hydrophob
catalyt
amino
acid
residu
found
close
proxim
ligand
distanc
less
insuffici
form
hydrophob
interact
indic
ligand
might
inhibit
proteas
activ
block
bind
substrat
activ
site
howev
conserv
residu
proteas
activ
site
pocket
present
close
proxim
catalyt
activ
proteas
reduc
interact
ligand
interestingli
none
ligand
found
involv
interact
proteas
six
ligand
bond
either
hydrogen
bond
hydrophob
interact
three
amino
acid
residu
creat
microenviron
proteas
activ
deriv
pyrazolelik
fig
synthes
jadav
et
al
examin
antivir
activ
chiv
vero
cell
cultur
cpe
reduct
assay
three
aralkyliden
deriv
compound
orthomethylsubstitut
ligand
found
activ
among
rest
furthermor
understand
mechan
protein
ligand
interact
molecular
dock
carri
chikv
proteas
pdb
result
show
strong
interact
aralkyliden
three
amino
acid
thiazolidinon
show
strong
hydrophob
interact
compound
found
antivir
activ
low
concentr
particularli
compound
potent
among
aforement
compound
methyl
substitut
orthoposit
compound
favor
found
time
potent
paracounterpart
compound
aralkyliden
portion
get
accommod
exhibit
two
hbond
interact
compound
similarli
compound
show
interact
residu
exhibit
hbond
interact
thiazolidon
deriv
exhibit
hydrogenbind
interact
proteas
interact
carbonyl
oxygen
thiazolidon
backbon
amid
hydrogen
hydrogen
thiazolidon
nitrogen
aforement
compound
like
crystallin
structur
ntermin
domain
also
becam
great
use
posit
potenti
drug
target
develop
antivir
drug
identifi
potenti
inhibitor
nguyen
et
al
screen
compound
nci
divers
set
chikv
identifi
potenti
inhibitor
target
chikv
complex
adpribos
identifi
possibl
bind
pocket
virtual
screen
carri
use
three
step
first
step
dock
center
adpribosebind
site
second
step
blind
dock
center
middl
adpribosebind
site
third
step
dock
center
bide
site
predict
meatpack
led
identif
top
compound
shown
fig
bind
energi
kcalmol
furthermor
result
also
indic
proteas
residu
interact
ligand
hydrophob
contact
residu
play
crucial
role
stabil
complex
bind
energi
adpribos
less
kcalmol
show
neg
charg
ligand
bind
strongli
bind
affin
three
differ
bind
pocket
studi
dock
analysi
reveal
hit
pocket
bind
protein
well
bind
energi
less
kcalmol
hydrogen
bond
hydrophob
interact
play
import
role
bind
ligand
differ
conform
ligand
bind
differ
pocket
pocket
might
good
locat
bind
compar
pocket
associ
higher
bind
affin
hydrogenbond
interact
play
import
role
bind
pocket
wherea
hydrophob
contact
respons
interact
associ
bind
pocket
effort
identifi
novel
inhibitor
proteas
kaur
et
al
extens
studi
natur
compound
librari
studi
led
identif
compound
exhibit
inhibit
chikv
viru
pathogenesi
harringtonin
cephalotaxin
alkaloid
fig
display
potent
inhibit
activ
chikv
infect
minim
cytotox
studi
kaur
et
al
elucid
antivir
mechan
harringtonin
inhibit
chikv
replic
cycl
occur
viral
entri
cell
addit
studi
cotreat
assay
direct
transfect
viral
genom
rna
also
affect
chikv
rna
product
well
viral
protein
express
concentr
show
higher
magnitud
inhibit
viru
titer
cepholotoxin
plant
alkaloid
harringtonin
display
strong
ec
less
cytotox
inhibitori
activ
these
compound
test
viru
cellbas
immunofluoresc
assay
recent
immunofluorescencebas
screen
perform
potenti
inhibitor
chikv
use
natur
compound
librari
harringtonin
acephalotoxin
alkaloid
display
ec
less
cytotox
fig
silymarin
extract
milk
thistl
shown
inhibit
hepat
c
viru
complex
seven
flavonolignan
silybin
silybin
b
fig
isosilybin
isosilybin
b
silychristin
isosilychristin
silydianin
flavonoid
silymarin
abl
suppress
activ
rluc
marker
fuse
protein
viru
lani
et
al
plantderiv
flavonoid
polyphenol
compound
endow
wide
rang
biolog
benefit
human
health
includ
antiinflammatori
antioxid
antibacteri
antifung
activ
also
antivir
activ
increas
number
drugresist
microorgan
brought
natur
compound
flavonoid
forefront
import
natur
resourc
overcom
problem
number
studi
success
shown
variou
type
flavonoid
rutin
naringin
baicalein
quercetin
kaempferol
potenti
antivir
agent
wide
rang
import
virus
includ
dengu
viru
influenza
viru
coxsackieviru
japanes
enceph
viru
seyedi
et
al
baicalin
metabolit
baicalein
extract
root
chines
medicin
herbal
plant
scutellaria
baicalensi
baicalin
also
serv
potenti
antivir
agent
influenza
virus
act
neuraminidas
inhibitor
seyedi
et
al
screen
potenc
three
flavonoid
baicalin
naringenin
quercetagetin
fig
target
protein
chikv
viru
use
comput
approach
dock
result
show
three
test
ligand
baicalin
show
highest
bind
affin
kcalmol
bind
energi
low
k
valu
follow
quercetagetin
naringenin
bind
energi
kcalmol
respect
hydrogenbond
donor
came
protein
residu
correspond
acceptor
deriv
ligand
ligand
interact
residu
present
activ
site
baicalin
naringenin
quercetagetin
one
interact
found
baicalin
residu
chikv
proteas
amino
acid
form
catalyt
triad
nearbi
residu
proxim
act
activ
site
kumar
et
al
identifi
one
core
bind
site
along
two
alloster
site
situat
palm
thumb
domain
dock
result
show
nucleosid
analog
best
dock
score
proteas
bind
energi
rang
kcalmol
kumar
et
al
nucleosid
inhibitor
ribavirin
fig
well
nonnucleosid
inhibitor
biln
fig
could
dock
catalyt
well
alloster
site
local
palm
well
thumb
domain
shown
fig
biln
show
highest
bind
affin
energi
kcalmol
palm
alloster
site
indol
benzimidazol
deriv
also
found
better
interact
chikv
palm
alloster
site
van
der
waal
interact
domin
hydrogenbond
interact
minimum
core
catalyt
specif
nucleosid
inhibitor
found
four
hydrogenbond
donor
hbd
seven
hydrogenbond
acceptor
hba
one
aromat
ring
r
minimum
core
nonnucleosid
inhibitor
relat
palm
alloster
site
found
one
hbd
four
hba
two
rs
three
hydrophob
region
ribavirin
nucleosid
analog
inhibitor
interact
catalyt
site
signific
bind
energi
nonnucleosid
inhibitor
biln
diketo
acid
deriv
show
better
interact
palm
thumb
alloster
site
respect
select
antivir
activ
favipiravir
replic
chikv
alphavirus
favipiravirresist
chikv
variant
carri
mutat
rdrp
studi
delang
et
al
author
also
studi
effect
favipiravir
nucleotid
prodrug
develop
treatment
influenza
character
viru
variant
cell
cultur
suggest
highli
conserv
part
viral
polymeras
positivestrand
rna
virus
target
favipiravir
mutat
also
found
favipiravirresist
chikv
variant
result
phenotyp
resist
favipiravir
shown
revers
genet
lysin
posit
locat
region
possess
high
degre
conserv
among
alphavirus
structur
favipiravir
fig
bound
activ
site
norwalk
viru
nwv
polymeras
structur
found
superimpos
cytosin
base
ctp
compar
origin
charg
arginin
side
chain
much
closer
favipiravirrtp
inhibitor
specif
interact
steric
repuls
observ
favipiravirrtp
favipiravirrtp
activ
metabolit
ribofuranosyl
triphosph
fig
shown
bind
affin
proteas
domain
metabol
experi
confirm
direct
effect
chikv
rna
synthesi
patel
h
jasarai
yt
kapoora
rg
explor
polymeras
activ
chikungunya
viral
non
structur
protein
use
molecular
model
epharmacophor
dock
studi
int
j
pharm
life
sci
vaccin
therapeut
strategi
requir
combat
virus
manag
viral
infect
epidem
situat
avail
vaccin
therapeut
strategi
combat
virus
limit
includ
viral
polymeras
inhibitor
recombin
interferon
boost
host
antivir
system
recent
proteas
inhibitor
success
develop
inhibit
manag
hepat
c
hiv
virus
present
chapter
shown
chikv
effect
target
chemic
interact
numer
cellular
protein
control
interferon
signal
gene
transcript
variou
form
scaffold
chemic
entiti
alreadi
consid
enhanc
capac
drug
molecul
target
nsp
crystallograph
structur
function
viral
key
protein
provid
necessari
inform
develop
potenti
target
inhibitor
viral
protein
develop
proteas
inhibitor
ultim
combat
diseas
aris
differ
virus
mayaro
viru
ross
river
viru
chiv
sinv
onyongnyong
viru
eastern
equin
enceph
viru
semliki
forest
viru
una
viru
venezuelan
equin
enceph
viru
tonat
viru
western
equin
enceph
viru
etc
although
signific
improv
made
direct
discov
novel
proteas
inhibitor
target
viral
nsp
lack
clinic
approv
drug
molecul
limit
protect
sudden
diseas
occurr
chapter
equip
use
inform
develop
chemic
librari
design
alphavirustarget
inhibitor
construct
pharmacophor
ligandbas
drug
design
increas
chanc
discoveri
smallmolecul
inhibitor
conclus
near
futur
nsp
inhibitorbas
discoveri
antivir
drug
need
consid
privat
public
organ
hope
groom
businessfriendli
sector
discoveri
effect
drug
base
nsp
inhibitor
would
realiti
